Global medical health screening services market size is expected to reach US$ 38.64 Bn by 2030, from US$ 26.56 Bn in 2023, by exhibiting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Medical health screening services refer to a range of medical tests that are conducted to detect diseases and assess a person's overall health status. These services help in early diagnosis of diseases, even before symptoms appear, thus enabling timely treatment and better health outcomes. The key advantage of medical screening is that it facilitates proactive healthcare rather than reactive care.
Global medical health screening services market is driven by factors such as rising prevalence of chronic diseases, growing awareness about early detection, favorable government initiatives, and advancements in screening technologies. The market is segmented into test type, setting type, sample type, end user, and region. By test type, the market is segmented into routine tests, non-routine tests, cancer screening tests, specialty tests, and others. The routine tests segment accounted for the largest share of the market in 2022. The large share of this segment is due to the huge volume of routine tests that are carried out for general health assessments.
Global Medical Health Screening Services Market Regional Insights:
- North America is the largest market for medical health screening services, with a market share of 35.1% in 2022. This is due to the high prevalence of chronic diseases, the growing awareness of the importance of preventive healthcare, and the government initiatives to promote preventive healthcare in the region.
- Europe is the second-largest market for medical health screening services, with a market share of 26.2% in 2022. The market growth in Europe is due to the rising prevalence of chronic diseases, the increasing demand for personalized medicine, and the growing awareness of the importance of preventive healthcare in the region.
- Asia Pacific is the fastest-growing market for medical health screening services, with a CAGR of 29.3% during the forecast period. The market growth in Asia Pacific is due to the increasing population, the rising prevalence of chronic diseases, and the growing awareness of the importance of preventive healthcare in the region.
Figure 1. Global Medical Health Screening Services Market Share (%), By Region, 2023
Analysts Viewpoint of the Global Medical Health Screening Services Market:
- Global medical health screening services market is poised to grow significantly in the near future. The major drivers of the market growth include an aging global population, increasing lifestyle diseases, and better awareness around early detection and preventive healthcare. Risks of chronic conditions like diabetes and heart disease are rising due to sedentary lifestyles and obesity. However, the market growth could be restrained by high costs of comprehensive medical tests and limited healthcare budgets around the world. Procedures like CT scans, Magnetic Resonance Imaging (MRIs), genetic testing is quite expensive. This may restrict widespread adoption of health screening, especially in price-sensitive developing markets. Nevertheless, increasing penetration of health insurance and emphasis on wellness programs are the new opportunities that are being witnessed in the market. More employers are incentivizing employees to undergo routine check-ups through subsidized plans. This could make health screening affordable for masses. The market also witnesses potential in customized packages for customers of different ages, backgrounds, and family histories.
Global Medical Health Screening Services Market Drivers:
- Increasing prevalence of chronic diseases: Rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer and others is a major factor driving the growth of the global medical health screening services market. Early diagnosis through regular screening can help in better management of these chronic diseases and improve health outcomes. According to World Health Organization (WHO), chronic diseases accounts for 71% of deaths globally each year. The increasing disease burden is resulting in greater adoption of multi-specialty health screenings and routine check-ups by people to assess overall health risks. This rising demand is fueling the growth of the global medical screening services market.
- Growing awareness and health consciousness: With growing focus on preventive healthcare, people are becoming more aware about the importance of routine health check-ups and early disease diagnosis. Many government and non-profit organizations are undertaking awareness campaigns to educate the masses about various screening tests available for disease detection. Moreover, the increasing health consciousness among people due to sedentary lifestyles and unhealthy diets is encouraging regular health assessments, thereby driving the demand for health screening services.
- Advancements in medical technologies: The introduction of advanced, non-invasive and painless screening tests is boosting the adoption of health screenings. Technologies like imaging techniques, genomic screening, minimally invasive tests and others allow quick and accurate diagnosis without any discomfort to patients. Also, the adoption of point-of-care tests and development of easy-to-use at-home screening kits provides convenience to patients. Such technological advancements are expected to improve access and compliance to routine screening, thus fueling the market growth.
- Favorable government policies and initiatives: Government funding and initiatives to promote routine health check-ups and make screening services affordable are contributing to the market growth. Many public and private insurance plans cover basic health screening costs for enrollees. Public awareness campaigns and free community-based health screening programs sponsored by governments aids in creating health literacy and drive adoption of screening services.
Medical Health Screening Services Market Report Coverage
||Market Size in 2023:
||US$ 26.56 Bn
|Historical Data for:
||2018 to 2022
||2023 - 2030
|Forecast Period 2023 to 2030 CAGR:
||2030 Value Projection:
||US$ 38.64 Bn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Test Type: Routine Tests, Non-Routine Tests, Cancer Screening Tests, Specialty Tests, and Others
- By Setting Type: Hospitals/Clinical Laboratories, Workplaces, Ambulatory Care Centers, Multi-specialty Clinics, Diagnostic Imaging Centers, and Others
- By Sample Type: Blood, Urine, Saliva, and Others
- By End User: Hospitals/Clinics, Diagnostic Laboratories, Workplaces, Research Institutes, Others
Quest Diagnostics, Eurofins Scientific, SYNLAB International, Sonic Healthcare, LabCorp, Unilabs, Lifelabs, Healthscope, Clinical Reference Laboratory, and ACM Medical Laboratory
- Increasing prevalence of chronic diseases
- Growing awareness and health consciousness
- Advancements in medical technologies
- Favorable government policies and initiatives
|Restraints & Challenges:
- High costs and uncertain reimbursement scenario
- Shortage of trained healthcare professionals
- Low awareness in developing countries
Global Medical Health Screening Services Market Opportunities:
- Emerging economies offer significant growth prospects: Developing nations present immense opportunities due to improving healthcare infrastructure, rising incomes, and health awareness. The lower penetration of screening services in these economies due to lack of facilities and high costs presents highlights untapped potential market opportunities. Local governments are undertaking various initiatives to provide affordable and accessible screening options to populations. This creates substantial opportunities for growth and expansion for providers in emerging markets.
- Innovative business models and strategies: Market players in the health screening services have opportunities to pursue strategies like partnerships with employers and provide on-site screening programs and bundling of tests to drive revenues. Tie-ups with wellness programs, gyms, clinics and others allow access to wider customer segments. Providers can also adopt retail health models and offer self-pay screening packages to attract individual customers. Such innovative models can boost adoption and create new revenue streams.
- Growing workplace screening segment: The workplace screening services segment is expected to exhibit the highest growth due to the employer interest in workforce health management, and providing preventive care benefits. The workplace screening programs to assess health risks in employees are also gaining traction. Service providers can partner with employers seeking to implement routine staff health check-ups, thus presenting significant opportunities for market expansion.
- Widening screening applications: Advances in genomic testing, biomarkers, and Artificial Intelligence (AI) are expanding screening applications for detecting mental health conditions, neurological disorders, and inheritable diseases for predicting susceptibility to future illnesses which are based on genetic makeup. The introduction of new screening tests for unconventional conditions beyond standard check-ups presents potential for service diversification.
Global Medical Health Screening Services Market Trends:
- Increasing adoption of multi-specialty screening: The demand for comprehensive and integrated health check-ups by encompassing a suite of tests for different conditions is rising due to greater convenience and cost-effectiveness. Multi-specialty screening panels covering heart, diabetes, cancer, thyroid, and others allow evaluation of overall health status in a single appointment. Providers are offering bundled preventive health packages thus catering to the rising preference for multi-specialty tests.
- Growing popularity of direct-to-consumer testing: Direct access of patients to screening services is increasing due to rising consumerism in healthcare. Availability of at-home testing kits through e-commerce gives customers the convenience of getting tested from home. Growing number of private diagnostic labs and collection centers provide easy access. Direct marketing initiatives of service providers also boost consumer engagement. This emerging direct-to-customer channel presents an accelerating trend.
- Use of advanced digital technologies: Service providers are adopting advanced digital tools to enhance operational efficiency and improve customer experience. Technologies like electronic test ordering, automated result delivery, telemedicine, and online portals allow remote accessibility. Analytics solutions offer insights into patient data to support screening programs. Robotic process automation also accelerates workflows. The incorporation of digital technologies enables optimization and differentiation.
- Increasing consolidation of market players: The health screening landscape is witnessing increasing mergers and acquisitions as large players acquire smaller companies to expand geographic presence and service portfolio. Large diagnostics chains are acquiring imaging centers, specialty clinics, and telehealth startups. Collaboration with medical device companies is also rising due to integrate cutting-edge technologies. These consolidations allow providers to gain market share and strengthen foothold.
Global Medical Health Screening Services Market Restraints:
- High costs and uncertain reimbursement scenario: The high costs of some specialized tests and complex diagnostic procedures may hamper adoption of medical health screening services among population segments with lower disposable incomes. Also, limited coverage by payers and insurers due to lack of supportive policies hinders access to screening. Individuals bear the bulk of costs in the absence of adequate coverage, thus restricting demand for tests which are perceived as non-essential. This poses a restraint for market growth.
- Shortage of trained healthcare professionals: The shortage of adequately skilled personnel required to administer and interpret screening tests can restrict market growth, especially in developing nations. Complex molecular and genetic screening requires specialized pathologists and technicians. Lack of such trained professionals may act as a challenging factor by impacting timely result delivery and quality of outcomes. This can negatively influence patient experience.
- Low awareness in developing countries: Despite the growing incidence of lifestyle diseases, health literacy regarding preventive screening remains low in developing countries. Moreover, cultural barriers and social stigma which are associated with certain disease conditions also impedes uptake of medical tests. Lack of awareness about benefits of early screening and disease management hampers growth prospects of the market in untapped emerging economies.
- Counterbalance: The market players should provide proper reimbursement policy for the individual who are undertaking the health screening services. The cultural and the social barriers needs to be removed, mostly in the developing countries, to make people aware of the benefits of the early screening and detection of the disease. In carrying out the above mentioned counterbalances, there should be availability of trained and efficient professionals in performing the tasks diligently.
Figure 2. Global Medical Health Screening Services Market Share (%), By Test Type, 2023
New product launches:
- In May 2023, Index Medical Systems, a healthcare company received regulatory approval from the National Medical Products Administration (NMPA), China to launch over 30 medical tests in the areas of oncology, women's health, and general wellness screening in China. These will allowIndex to tap into China's large preventive healthcare screening industry and provide quality healthcare services to more Chinese citizens.
- In July 2022, Bloom Diagnostics, a medtech startup launched its new Bloom Inflammation Test, which measures C-reactive protein (CRP) in the bloodstream to detect inflammation in the body.
- In May 2022, QIAGEN NV, provider of sample and assay technologies for molecular diagnostics launched the QIAstat Dx Rise and advanced panels. QIA stat-Dx Rise and its test cartridges are a closed system for manual sample preparation and processing.
- In January 2022, health screening provider Practo, a mhealth platform launched diabetes screening services across various cities in India. Practo started providing HbA1c, fasting and post-meal blood sugar screening at affordable prices through a network of partner labs. This expanded Practo's preventive health screening portfolio and enabled more accessibility to diabetes screening services in India
- In June 2021, Grail, a healthcare company introduced the Galleri diagnostic, a single blood test capable of detecting the presence of numerous malignancies. The test is intended to check patients who are already at a high risk of cancer, such as persons over the age of 50.
Top Companies in Global Medical Health Screening Services Market:
- Quest Diagnostics
- Eurofins Scientific
- SYNLAB International
- Sonic Healthcare
- Clinical Reference Laboratory
- ACM Medical Laboratory
*Definition: Medical health screening refers to a range of medical tests and assessments that are conducted on asymptomatic individuals to detect diseases or abnormalities at an early stage, often before symptoms appear. It facilitates proactive healthcare by enabling timely intervention, which improves health outcomes. Some common medical screening tests include cholesterol, diabetes, cancer, cardiovascular disease, sexual health testing, and general health assessments. These services are provided through hospitals, clinics, diagnostic laboratories, workplaces, and dedicated health screening centers
Few Other Promising Reports in Medical Imaging Industry
Leukemia Screening Market
New Born Screening Market
Drug Screening Market
Cellular Health Screening Test Market